Leslie Gold

LeslieGold_CalRegen

Tissue Regeneration Sciences, Inc (TRS)

2018

Affiliations

New York University

Technologies

Therapeutic

Indication

Basic Research

Clinical Research

Dermatology

Drug Discovery

Fibrosis

Personalized Medicine

Regenerative Medicine

Executive Summary

View/Download

Tissue Regeneration Sciences, Inc (TRS) (Previously CalRegen, Inc) is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.

 

Newsletter Signup

Corporate Supporters

ABCT is a Program of

An intiative of